ENTRY       D09620                      Drug
NAME        Fresolimumab (USAN/INN)
FORMULA     C6392H9926N1698O2026S44
EXACT_MASS  144297.3591
MOL_WEIGHT  144386.2278
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGSSVKV SCKASGYTFS SNVISWVRQA PGQGLEWMGG VIPIVDIANY
            AQRFKGRVTI TADESTSTTY MELSSLRSED TAVYYCASTL GLVLDAMDYW GQGTLVTVSS
            ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTKT YTCNVDHKPS NTKVDKRVES KYGPPCPSCP APEFLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSQED PEVQFNWYVD GVEVHNAKTK PREEQFNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK GQPREPQVYT LPPSQEEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSRL TVDKSRWQEG
            NVFSCSVMHE ALHNHYTQKS LSLSLGK
            (Light chain)
            ETVLTQSPGT LSLSPGERAT LSCRASQSLG SSYLAWYQQK PGQAPRLLIY GASSRAPGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYADSPITFG QGTRLEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H147-H203, H261-H321, H367-H425, H226-H'226, H229-H'229, L23-L89, L135-L195, H134-L215)
  TYPE      Peptide
EFFICACY    Immunomodulator, Anti-transforming growth factor beta antibody
  TYPE      Monoclonal antibody
COMMENT     Idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer
TARGET      TGFB [HSA:7040 7042 7043] [KO:K13375 K13376 K13377]
  PATHWAY   hsa04010(7040+7042+7043)  MAPK signaling pathway
            hsa04060(7040+7042+7043)  Cytokine-cytokine receptor interaction
            hsa04350(7040+7042+7043)  TGF-beta signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Transforming growth factors (RSTK-binding)
                TGFB
                 D09620  Fresolimumab (USAN/INN)
DBLINKS     CAS: 948564-73-6
            PubChem: 124490360
///
